HMGB1 and Alzheimer disease: Interestingly, the serum level of HMGB1 was not different between patients with cCLD and dCLD at baseline but was significantly elevated in patients with compensated CLD developing AD during follow versus patients with stably compensated CLD (P = 0.03).